User Posts: admin3
0
My Cancer ‘Surviving Strategies’
0

I was in disbelief when I was diagnosed with cancer, but then I turned my attention to crafting my surviving strategies.“Cancer? Not me! Impossible!”That ...

0
What Does it Mean to be a Fighter?
0

When I tell my cancer journey story, many exclaim, “You’re such a strong woman!” When I tell them I fought leukemia twice and had a bone marrow transplant, ...

0
FDA Approves Onivyde as First-Line Treatment of Metastatic Pancreatic Cancer
0

The Food and Drug Administration (FDA) has approved Onivyde (irinotecan liposome) with oxaliplatin, fluorouracil and leucovorin, for the first-line ...

0
Novel Drug Granted FDA Fast Track in Rare Prostate Cancer Subset
0

The FDA granted a Fast Track designation for a novel drug to treat a rare form of prostate cancer. The Food and Drug Administration (FDA) has granted a Fast ...

0
Gut Microbiota Differs in Patients With MPNs
0

Certain patients with myeloproliferative neoplasms had different gut microbiota than healthy controls. The gut microbiota in patients with ...

0
A Letter to King Charles III After His Cancer Diagnosis
0

Your Majesty,How’s it going for you across the pond? I’d like to personally welcome you to the Guild of Malignant Mysteries (AKA the "Cancer Club"). It’s an ...

0
Novel Drug Improves Survival in Advanced Brain Cancer
0

A novel drug has been found to improve survival and reduce cognitive decline in some patients with advanced brain cancer. A new novel drug has been found to ...

0
Guidelines for Childhood Neuroblastoma, FDA Decisions and More
0

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority ...

0
Overcoming Cancer Helped Me Step Out of My Comfort Zone
0

In a few months, I’ll have survived cancer for 10 years. When I was first diagnosed, I thought I’d die shortly thereafter, but that’s not what happened. I ...

0
Phase 2 Trial Assessing Novel TKI Begins in ALK-Positive NSCLC, Solid Tumors
0

A novel TKI is being evaluated in a phase 2 trial for patients with ALK-positive NSCLC.The phase 2 portion of the ALKOVE-1 trial has started and aims to ...

User Deals: admin3
Browsing All Comments By: admin3
CML Alliance
Logo
Enable registration in settings - general
Compare items
  • Total (0)
Compare
0
Shopping cart